메뉴 건너뛰기




Volumn 13, Issue 1, 2015, Pages

Induction of tumor inhibitory anti-angiogenic response through immunization with interferon Gamma primed placental endothelial cells: ValloVax™

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; INTERFERON GAMMA PRIMED PLACENTAL ENDOTHELIAL CELL VACCINE; UNCLASSIFIED DRUG; GAMMA INTERFERON;

EID: 84924912033     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-015-0441-0     Document Type: Article
Times cited : (8)

References (69)
  • 2
    • 0034669980 scopus 로고    scopus 로고
    • IFN-gamma can promote tumor evasion of the immune system in vivo by down-regulating cellular levels of an endogenous tumor antigen
    • Beatty GL, Paterson Y. IFN-gamma can promote tumor evasion of the immune system in vivo by down-regulating cellular levels of an endogenous tumor antigen. J Immunol. 2000;165(10):5502-8.
    • (2000) J Immunol , vol.165 , Issue.10 , pp. 5502-5508
    • Beatty, G.L.1    Paterson, Y.2
  • 3
    • 34147101048 scopus 로고    scopus 로고
    • HER-2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell-mediated anti-tumor immune responses
    • Kmieciak M, Knutson KL, Dumur CI, Manjili MH. HER-2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell-mediated anti-tumor immune responses. Eur J Immunol. 2007;37(3):675-85.
    • (2007) Eur J Immunol , vol.37 , Issue.3 , pp. 675-685
    • Kmieciak, M.1    Knutson, K.L.2    Dumur, C.I.3    Manjili, M.H.4
  • 4
    • 12444262173 scopus 로고    scopus 로고
    • Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy
    • Chang CC, Campoli M, Restifo NP, Wang X, Ferrone S. Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy. J Immunol. 2005;174(3):1462-71.
    • (2005) J Immunol , vol.174 , Issue.3 , pp. 1462-1471
    • Chang, C.C.1    Campoli, M.2    Restifo, N.P.3    Wang, X.4    Ferrone, S.5
  • 5
    • 0033991158 scopus 로고    scopus 로고
    • Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance
    • Marincola FM, Jaffee EM, Hicklin DJ, Ferrone S. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv Immunol. 2000;74:181-273.
    • (2000) Adv Immunol , vol.74 , pp. 181-273
    • Marincola, F.M.1    Jaffee, E.M.2    Hicklin, D.J.3    Ferrone, S.4
  • 6
    • 0032525339 scopus 로고    scopus 로고
    • beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma
    • Hicklin DJ, Wang Z, Arienti F, Rivoltini L, Parmiani G, Ferrone S. beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma. J Clin Invest. 1998;101(12):2720-9.
    • (1998) J Clin Invest , vol.101 , Issue.12 , pp. 2720-2729
    • Hicklin, D.J.1    Wang, Z.2    Arienti, F.3    Rivoltini, L.4    Parmiani, G.5    Ferrone, S.6
  • 7
    • 0020587302 scopus 로고
    • Striking paucity of HLA-A, B, C and beta 2-microglobulin on human neuroblastoma cell lines
    • Lampson LA, Fisher CA, Whelan JP. Striking paucity of HLA-A, B, C and beta 2-microglobulin on human neuroblastoma cell lines. J Immunol. 1983;130(5):2471-8.
    • (1983) J Immunol , vol.130 , Issue.5 , pp. 2471-2478
    • Lampson, L.A.1    Fisher, C.A.2    Whelan, J.P.3
  • 8
    • 79953021083 scopus 로고    scopus 로고
    • HLA-G expression in cancers: potential role in diagnosis, prognosis and therapy
    • Yan WH. HLA-G expression in cancers: potential role in diagnosis, prognosis and therapy. Endocr Metab Immune Disord Drug Targets. 2011;11(1):76-89.
    • (2011) Endocr Metab Immune Disord Drug Targets , vol.11 , Issue.1 , pp. 76-89
    • Yan, W.H.1
  • 9
    • 84891779838 scopus 로고    scopus 로고
    • B7-H abnormalities in melanoma and clinical relevance
    • Seliger B. B7-H abnormalities in melanoma and clinical relevance. Methods Mol Biol. 2014;1102:367-80.
    • (2014) Methods Mol Biol , vol.1102 , pp. 367-380
    • Seliger, B.1
  • 10
    • 84868288550 scopus 로고    scopus 로고
    • Anti-tumor immunity: myeloid leukocytes control the immune landscape
    • Rutkowski MR, Stephen TL, Conejo-Garcia JR. Anti-tumor immunity: myeloid leukocytes control the immune landscape. Cell Immunol. 2012;278(1-2):21-6.
    • (2012) Cell Immunol , vol.278 , Issue.1-2 , pp. 21-26
    • Rutkowski, M.R.1    Stephen, T.L.2    Conejo-Garcia, J.R.3
  • 11
    • 0034648765 scopus 로고    scopus 로고
    • Angiogenesis in cancer and other diseases
    • Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407(6801):249-57.
    • (2000) Nature , vol.407 , Issue.6801 , pp. 249-257
    • Carmeliet, P.1    Jain, R.K.2
  • 12
    • 0026846928 scopus 로고
    • The role of angiogenesis in tumor growth
    • Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol. 1992;3(2):65-71.
    • (1992) Semin Cancer Biol , vol.3 , Issue.2 , pp. 65-71
    • Folkman, J.1
  • 13
    • 84902124970 scopus 로고    scopus 로고
    • Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
    • Motz GT, Santoro SP, Wang LP, Garrabrant T, Lastra RR, Hagemann IS, et al. Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors. Nat Med. 2014;20(6):607-15.
    • (2014) Nat Med , vol.20 , Issue.6 , pp. 607-615
    • Motz, G.T.1    Santoro, S.P.2    Wang, L.P.3    Garrabrant, T.4    Lastra, R.R.5    Hagemann, I.S.6
  • 14
    • 84897498641 scopus 로고    scopus 로고
    • Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature
    • Facciponte JG, Ugel S, De Sanctis F, Li C, Wang L, Nair G, et al. Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature. J Clin Invest. 2014;124(4):1497-511.
    • (2014) J Clin Invest , vol.124 , Issue.4 , pp. 1497-1511
    • Facciponte, J.G.1    Ugel, S.2    Sanctis, F.3    Li, C.4    Wang, L.5    Nair, G.6
  • 15
    • 84874665041 scopus 로고    scopus 로고
    • Enhanced radioresponse with a novel recombinant human endostatin protein via tumor vasculature remodeling: experimental and clinical evidence
    • Meng MB, Jiang XD, Deng L, Na FF, He JZ, Xue JX, et al. Enhanced radioresponse with a novel recombinant human endostatin protein via tumor vasculature remodeling: experimental and clinical evidence. Radiother Oncol. 2013;106(1):130-7.
    • (2013) Radiother Oncol , vol.106 , Issue.1 , pp. 130-137
    • Meng, M.B.1    Jiang, X.D.2    Deng, L.3    Na, F.F.4    He, J.Z.5    Xue, J.X.6
  • 17
    • 84859501370 scopus 로고    scopus 로고
    • Recombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma models
    • Peng F, Xu Z, Wang J, Chen Y, Li Q, Zuo Y, et al. Recombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma models. PLoS One. 2012;7(4):e34646.
    • (2012) PLoS One , vol.7 , Issue.4 , pp. e34646
    • Peng, F.1    Xu, Z.2    Wang, J.3    Chen, Y.4    Li, Q.5    Zuo, Y.6
  • 19
    • 77957890055 scopus 로고    scopus 로고
    • Endothelial membrane remodeling is obligate for anti-angiogenic radiosensitization during tumor radiosurgery
    • 19
    • Truman JP, García-Barros M, Kaag M, Hambardzumyan D, Stancevic B, Chan M et al. Endothelial membrane remodeling is obligate for anti-angiogenic radiosensitization during tumor radiosurgery. PLoS One. 2010;19;5(8):e12310.
    • (2010) PLoS One , vol.5 , Issue.8 , pp. e12310
    • Truman, J.P.1    García-Barros, M.2    Kaag, M.3    Hambardzumyan, D.4    Stancevic, B.5    Chan, M.6
  • 20
    • 38749147680 scopus 로고    scopus 로고
    • Pilot study of anti-angiogenic vaccine using fixed whole endothelium in patients with progressive malignancy after failure of conventional therapy
    • Okaji Y, Tsuno NH, Tanaka M, Yoneyama S, Matsuhashi M, Kitayama J, et al. Pilot study of anti-angiogenic vaccine using fixed whole endothelium in patients with progressive malignancy after failure of conventional therapy. Eur J Cancer. 2008;44(3):383-90.
    • (2008) Eur J Cancer , vol.44 , Issue.3 , pp. 383-390
    • Okaji, Y.1    Tsuno, N.H.2    Tanaka, M.3    Yoneyama, S.4    Matsuhashi, M.5    Kitayama, J.6
  • 21
    • 0033582914 scopus 로고    scopus 로고
    • Slit proteins bind Robo receptors and have an evolutionarily conserved role in repulsive axon guidance
    • Brose K, Bland KS, Wang KH, Arnott D, Henzel W, Goodman CS, et al. Slit proteins bind Robo receptors and have an evolutionarily conserved role in repulsive axon guidance. Cell. 1999;96(6):795-806.
    • (1999) Cell , vol.96 , Issue.6 , pp. 795-806
    • Brose, K.1    Bland, K.S.2    Wang, K.H.3    Arnott, D.4    Henzel, W.5    Goodman, C.S.6
  • 22
    • 84896872807 scopus 로고    scopus 로고
    • Role of ROBO4 signalling in developmental and pathological angiogenesis
    • Yadav SS, Narayan G. Role of ROBO4 signalling in developmental and pathological angiogenesis. Biomed Res Int. 2014;2014:683025.
    • (2014) Biomed Res Int , vol.2014 , pp. 683025
    • Yadav, S.S.1    Narayan, G.2
  • 24
    • 79960583175 scopus 로고    scopus 로고
    • CD133 positive progenitor endothelial cell lines from human cord blood
    • Paprocka M, Krawczenko A, Dus D, Kantor A, Carreau A, Grillon C, et al. CD133 positive progenitor endothelial cell lines from human cord blood. Cytometry A. 2011;79(8):594-602.
    • (2011) Cytometry A , vol.79 , Issue.8 , pp. 594-602
    • Paprocka, M.1    Krawczenko, A.2    Dus, D.3    Kantor, A.4    Carreau, A.5    Grillon, C.6
  • 25
    • 78649487518 scopus 로고    scopus 로고
    • Adult endothelial progenitor cells retain hematopoiesis potential
    • Chen C, Zeng L, Ding S, Xu K. Adult endothelial progenitor cells retain hematopoiesis potential. Transplant Proc. 2010;42(9):3745-9.
    • (2010) Transplant Proc , vol.42 , Issue.9 , pp. 3745-3749
    • Chen, C.1    Zeng, L.2    Ding, S.3    Xu, K.4
  • 26
    • 35649022695 scopus 로고    scopus 로고
    • Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin alpha(6)
    • Smadja DM, Bièche I, Helley D, Laurendeau I, Simonin G, Muller L, et al. Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin alpha(6). J Cell Mol Med. 2007;11(5):1149-61.
    • (2007) J Cell Mol Med , vol.11 , Issue.5 , pp. 1149-1161
    • Smadja, D.M.1    Bièche, I.2    Helley, D.3    Laurendeau, I.4    Simonin, G.5    Muller, L.6
  • 27
    • 0038806646 scopus 로고    scopus 로고
    • Angiogenic factors reconstitute hematopoiesis by recruiting stem cells from bone marrow microenvironment
    • Rafii S, Avecilla S, Shmelkov S, Shido K, Tejada R, Moore MA, et al. Angiogenic factors reconstitute hematopoiesis by recruiting stem cells from bone marrow microenvironment. Ann N Y Acad Sci. 2003;996:49-60.
    • (2003) Ann N Y Acad Sci , vol.996 , pp. 49-60
    • Rafii, S.1    Avecilla, S.2    Shmelkov, S.3    Shido, K.4    Tejada, R.5    Moore, M.A.6
  • 28
    • 0036344496 scopus 로고    scopus 로고
    • Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment
    • Hattori K, Heissig B, Wu Y, Dias S, Tejada R, Ferris B, et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat Med. 2002;8(8):841-9.
    • (2002) Nat Med , vol.8 , Issue.8 , pp. 841-849
    • Hattori, K.1    Heissig, B.2    Wu, Y.3    Dias, S.4    Tejada, R.5    Ferris, B.6
  • 30
    • 84874706301 scopus 로고    scopus 로고
    • Active immunotherapy for mouse breast cancer with irradiated whole-cell vaccine expressing VEGFR2
    • Yan HX, Cheng P, Wei HY, Shen GB, Fu LX, Ni J, et al. Active immunotherapy for mouse breast cancer with irradiated whole-cell vaccine expressing VEGFR2. Oncol Rep. 2013;29(4):1510-6.
    • (2013) Oncol Rep , vol.29 , Issue.4 , pp. 1510-1516
    • Yan, H.X.1    Cheng, P.2    Wei, H.Y.3    Shen, G.B.4    Fu, L.X.5    Ni, J.6
  • 31
    • 27644541376 scopus 로고    scopus 로고
    • Anti-angiogenesis effect on glioma of attenuated Salmonella typhimurium vaccine strain with flk-1 gene
    • Feng K, Zhao H, Chen J, Yao D, Jiang X, Zhou W, et al. Anti-angiogenesis effect on glioma of attenuated Salmonella typhimurium vaccine strain with flk-1 gene. J Huazhong Univ Sci Technolog Med Sci. 2004;24(4):389-91.
    • (2004) J Huazhong Univ Sci Technolog Med Sci , vol.24 , Issue.4 , pp. 389-391
    • Feng, K.1    Zhao, H.2    Chen, J.3    Yao, D.4    Jiang, X.5    Zhou, W.6
  • 32
    • 19644378474 scopus 로고    scopus 로고
    • Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2
    • Wada S, Tsunoda T, Baba T, Primus FJ, Kuwano H, Shibuya M, et al. Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2. Cancer Res. 2005;65(11):4939-46.
    • (2005) Cancer Res , vol.65 , Issue.11 , pp. 4939-4946
    • Wada, S.1    Tsunoda, T.2    Baba, T.3    Primus, F.J.4    Kuwano, H.5    Shibuya, M.6
  • 33
    • 70249149616 scopus 로고    scopus 로고
    • A promising new approach of VEGFR2-based DNA vaccine for tumor immunotherapy
    • Yan J, Jia R, Song H, Liu Y, Zhang L, Zhang W, et al. A promising new approach of VEGFR2-based DNA vaccine for tumor immunotherapy. Immunol Lett. 2009;126(1-2):60-6.
    • (2009) Immunol Lett , vol.126 , Issue.1-2 , pp. 60-66
    • Yan, J.1    Jia, R.2    Song, H.3    Liu, Y.4    Zhang, L.5    Zhang, W.6
  • 34
    • 79960559171 scopus 로고    scopus 로고
    • Inhibition of tumor angiogenesis in lung cancer by T4 phage surface displaying mVEGFR2 vaccine
    • Ren S, Fengyu, Zuo S, Zhao M, Wang X, Wang X et al. Inhibition of tumor angiogenesis in lung cancer by T4 phage surface displaying mVEGFR2 vaccine. Vaccine. 2011;29(34):5802-11.
    • (2011) Vaccine , vol.29 , Issue.34 , pp. 5802-5811
    • Ren, S.1    Fengyu2    Zuo, S.3    Zhao, M.4    Wang, X.5    Wang, X.6
  • 35
    • 84862102961 scopus 로고    scopus 로고
    • Enhancement of DNA vaccine efficacy by targeting the xenogeneic human chorionic gonadotropin, survivin and vascular endothelial growth factor receptor 2 combined tumor antigen to the major histocompatibility complex class II pathway
    • Wei Y, Sun Y, Song C, Li H, Li Y, Zhang K, et al. Enhancement of DNA vaccine efficacy by targeting the xenogeneic human chorionic gonadotropin, survivin and vascular endothelial growth factor receptor 2 combined tumor antigen to the major histocompatibility complex class II pathway. J Gene Med. 2012;14(5):353-62.
    • (2012) J Gene Med , vol.14 , Issue.5 , pp. 353-362
    • Wei, Y.1    Sun, Y.2    Song, C.3    Li, H.4    Li, Y.5    Zhang, K.6
  • 36
    • 84875930616 scopus 로고    scopus 로고
    • Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer
    • Suzuki H, Fukuhara M, Yamaura T, Mutoh S, Okabe N, Yaginuma H, et al. Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer. J Transl Med. 2013;11:97.
    • (2013) J Transl Med , vol.11 , pp. 97
    • Suzuki, H.1    Fukuhara, M.2    Yamaura, T.3    Mutoh, S.4    Okabe, N.5    Yaginuma, H.6
  • 37
    • 70350107237 scopus 로고    scopus 로고
    • Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma
    • Lladser A, Ljungberg K, Tufvesson H, Tazzari M, Roos AK, Quest AF, et al. Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma. Cancer Immunol Immunother. 2010;59(1):81-92.
    • (2010) Cancer Immunol Immunother , vol.59 , Issue.1 , pp. 81-92
    • Lladser, A.1    Ljungberg, K.2    Tufvesson, H.3    Tazzari, M.4    Roos, A.K.5    Quest, A.F.6
  • 38
    • 41149088925 scopus 로고    scopus 로고
    • Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis
    • Xiang R, Luo Y, Niethammer AG, Reisfeld RA. Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis. Immunol Rev. 2008;222:117-28.
    • (2008) Immunol Rev , vol.222 , pp. 117-128
    • Xiang, R.1    Luo, Y.2    Niethammer, A.G.3    Reisfeld, R.A.4
  • 39
    • 12544259115 scopus 로고    scopus 로고
    • A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication
    • Xiang R, Mizutani N, Luo Y, Chiodoni C, Zhou H, Mizutani M. A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication. Cancer Res. 2005;65(2):553-61.
    • (2005) Cancer Res , vol.65 , Issue.2 , pp. 553-561
    • Xiang, R.1    Mizutani, N.2    Luo, Y.3    Chiodoni, C.4    Zhou, H.5    Mizutani, M.6
  • 40
    • 1942487872 scopus 로고    scopus 로고
    • Generation of a specific immunological response to FGF-2 does not affect wound healing or reproduction
    • Plum SM, Vu HA, Mercer B, Fogler WE, Fortier AH. Generation of a specific immunological response to FGF-2 does not affect wound healing or reproduction. Immunopharmacol Immunotoxicol. 2004;26(1):29-41.
    • (2004) Immunopharmacol Immunotoxicol , vol.26 , Issue.1 , pp. 29-41
    • Plum, S.M.1    Vu, H.A.2    Mercer, B.3    Fogler, W.E.4    Fortier, A.H.5
  • 41
    • 0035949593 scopus 로고    scopus 로고
    • Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen
    • Wei YQ, Huang MJ, Yang L, Zhao X, Tian L, Lu Y, et al. Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen. Proc Natl Acad Sci U S A. 2001;98(20):11545-50.
    • (2001) Proc Natl Acad Sci U S A , vol.98 , Issue.20 , pp. 11545-11550
    • Wei, Y.Q.1    Huang, M.J.2    Yang, L.3    Zhao, X.4    Tian, L.5    Lu, Y.6
  • 42
    • 0041439704 scopus 로고    scopus 로고
    • Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2
    • Liu JY, Wei YQ, Yang L, Zhao X, Tian L, Hou JM, et al. Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2. Blood. 2003;102(5):1815-23.
    • (2003) Blood , vol.102 , Issue.5 , pp. 1815-1823
    • Liu, J.Y.1    Wei, Y.Q.2    Yang, L.3    Zhao, X.4    Tian, L.5    Hou, J.M.6
  • 43
    • 0037308585 scopus 로고    scopus 로고
    • Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2
    • Su JM, Wei YQ, Tian L, Zhao X, Yang L, He QM, et al. Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2. Cancer Res. 2003;63(3):600-7.
    • (2003) Cancer Res , vol.63 , Issue.3 , pp. 600-607
    • Su, J.M.1    Wei, Y.Q.2    Tian, L.3    Zhao, X.4    Yang, L.5    He, Q.M.6
  • 44
    • 4544236628 scopus 로고    scopus 로고
    • Active immunotherapy of tumors with a recombinant xenogeneic endoglin as a model antigen
    • Tan GH, Wei YQ, Tian L, Zhao X, Yang L, Li J, et al. Active immunotherapy of tumors with a recombinant xenogeneic endoglin as a model antigen. Eur J Immunol. 2004;34(7):2012-21.
    • (2004) Eur J Immunol , vol.34 , Issue.7 , pp. 2012-2021
    • Tan, G.H.1    Wei, Y.Q.2    Tian, L.3    Zhao, X.4    Yang, L.5    Li, J.6
  • 45
    • 33748487150 scopus 로고    scopus 로고
    • A plasmid DNA vaccine encoding the extracellular domain of porcine endoglin induces anti-tumour immune response against self endoglin-related angiogenesis in two liver cancer models
    • Jiao JG, Li YN, Wang H, Liu Q, Cao JX, Bai RZ, et al. A plasmid DNA vaccine encoding the extracellular domain of porcine endoglin induces anti-tumour immune response against self endoglin-related angiogenesis in two liver cancer models. Dig Liver Dis. 2006;38(8):578-87.
    • (2006) Dig Liver Dis , vol.38 , Issue.8 , pp. 578-587
    • Jiao, J.G.1    Li, Y.N.2    Wang, H.3    Liu, Q.4    Cao, J.X.5    Bai, R.Z.6
  • 46
    • 34948850204 scopus 로고    scopus 로고
    • Oxidative stress signalling: a potential mediator of tumour necrosis factor alpha-induced genomic instability in primary vascular endothelial cells
    • Natarajan M, Gibbons CF, Mohan S, Moore S, Kadhim MA. Oxidative stress signalling: a potential mediator of tumour necrosis factor alpha-induced genomic instability in primary vascular endothelial cells. Br J Radiol. 2007;80(Spec No 1):S13-22.
    • (2007) Br J Radiol , vol.80 , Issue.SPEC NO 1 , pp. S13-22
    • Natarajan, M.1    Gibbons, C.F.2    Mohan, S.3    Moore, S.4    Kadhim, M.A.5
  • 47
    • 84886773703 scopus 로고    scopus 로고
    • Heterogeneity of tumor endothelial cells
    • Hida K, Ohga N, Akiyama K, Maishi N, Hida Y. Heterogeneity of tumor endothelial cells. Cancer Sci. 2013;104(11):1391-5.
    • (2013) Cancer Sci , vol.104 , Issue.11 , pp. 1391-1395
    • Hida, K.1    Ohga, N.2    Akiyama, K.3    Maishi, N.4    Hida, Y.5
  • 48
    • 0033782775 scopus 로고    scopus 로고
    • Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine
    • Wei YQ, Wang QR, Zhao X, Yang L, Tian L, Lu Y, et al. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat Med. 2000;6(10):1160-6.
    • (2000) Nat Med , vol.6 , Issue.10 , pp. 1160-1166
    • Wei, Y.Q.1    Wang, Q.R.2    Zhao, X.3    Yang, L.4    Tian, L.5    Lu, Y.6
  • 49
    • 0038752102 scopus 로고    scopus 로고
    • Polyclonal antibodies to xenogeneic endothelial cells induce apoptosis and block support of tumor growth in mice
    • Scappaticci FA1, Contreras A, Boswell CA, Lewis JS, Nolan G. Polyclonal antibodies to xenogeneic endothelial cells induce apoptosis and block support of tumor growth in mice. Vaccine. 2003;21(19-20):2667-77.
    • (2003) Vaccine , vol.21 , Issue.19-20 , pp. 2667-2677
    • Scappaticci, F.A.1    Contreras, A.2    Boswell, C.A.3    Lewis, J.S.4    Nolan, G.5
  • 50
    • 84873715001 scopus 로고    scopus 로고
    • Human umbilical vein endothelial cell vaccine therapy in patients with recurrent glioblastoma
    • Tanaka M, Tsuno NH, Fujii T, Todo T, Saito N, Takahashi K. Human umbilical vein endothelial cell vaccine therapy in patients with recurrent glioblastoma. Cancer Sci. 2013;104(2):200-5.
    • (2013) Cancer Sci , vol.104 , Issue.2 , pp. 200-205
    • Tanaka, M.1    Tsuno, N.H.2    Fujii, T.3    Todo, T.4    Saito, N.5    Takahashi, K.6
  • 51
    • 84885423139 scopus 로고    scopus 로고
    • Enhanced antitumor efficacy by combination treatment with a human umbilical vein endothelial cell vaccine and a tumor cell lysate-based vaccine
    • Xu M, Zhou L, Zhang P, Lu Y, Ge C, Yao W, et al. Enhanced antitumor efficacy by combination treatment with a human umbilical vein endothelial cell vaccine and a tumor cell lysate-based vaccine. Tumour Biol. 2013;34(5):3173-82.
    • (2013) Tumour Biol , vol.34 , Issue.5 , pp. 3173-3182
    • Xu, M.1    Zhou, L.2    Zhang, P.3    Lu, Y.4    Ge, C.5    Yao, W.6
  • 52
    • 84895069468 scopus 로고    scopus 로고
    • Vaccination against tumour blood vessels in colorectal cancer
    • Ferguson HJ, Wragg J, Ismail T, Bicknell R. Vaccination against tumour blood vessels in colorectal cancer. Eur J Surg Oncol. 2014;40(2):133-6.
    • (2014) Eur J Surg Oncol , vol.40 , Issue.2 , pp. 133-136
    • Ferguson, H.J.1    Wragg, J.2    Ismail, T.3    Bicknell, R.4
  • 53
    • 66149085696 scopus 로고    scopus 로고
    • Vaccination with xenogeneic tumor endothelial proteins isolated in situ inhibits tumor angiogenesis and spontaneous metastasis
    • Zhang W, Liu JN, Tan XY. Vaccination with xenogeneic tumor endothelial proteins isolated in situ inhibits tumor angiogenesis and spontaneous metastasis. Int J Cancer. 2009;125(1):124-32.
    • (2009) Int J Cancer , vol.125 , Issue.1 , pp. 124-132
    • Zhang, W.1    Liu, J.N.2    Tan, X.Y.3
  • 54
    • 60849098452 scopus 로고    scopus 로고
    • Inhibition of B16 melanoma growth and metastasis in C57BL mice by vaccination with a syngeneic endothelial cell line
    • Yoshiura K, Nishishita T, Nakaoka T, Yamashita N, Yamashita N. Inhibition of B16 melanoma growth and metastasis in C57BL mice by vaccination with a syngeneic endothelial cell line. J Exp Clin Cancer Res. 2009;28:13.
    • (2009) J Exp Clin Cancer Res , vol.28 , pp. 13
    • Yoshiura, K.1    Nishishita, T.2    Nakaoka, T.3    Yamashita, N.4    Yamashita, N.5
  • 55
    • 33646174504 scopus 로고    scopus 로고
    • Vaccines targeting tumour angiogenesis-a novel strategy for cancer immunotherapy
    • Okaji Y, Tsuno NH, Saito S, Yoneyama S, Tanaka M, Nagawa H, et al. Vaccines targeting tumour angiogenesis-a novel strategy for cancer immunotherapy. Eur J Surg Oncol. 2006;32(4):363-70.
    • (2006) Eur J Surg Oncol , vol.32 , Issue.4 , pp. 363-370
    • Okaji, Y.1    Tsuno, N.H.2    Saito, S.3    Yoneyama, S.4    Tanaka, M.5    Nagawa, H.6
  • 56
    • 0034823182 scopus 로고    scopus 로고
    • Isolation of endothelial cells from human placental microvessels: effect of different proteolytic enzymes on releasing endothelial cells from villous tissue
    • Ugele B, Lange F. Isolation of endothelial cells from human placental microvessels: effect of different proteolytic enzymes on releasing endothelial cells from villous tissue. In Vitro Cell Dev Biol Anim. 2001;37(7):408-13.
    • (2001) In Vitro Cell Dev Biol Anim , vol.37 , Issue.7 , pp. 408-413
    • Ugele, B.1    Lange, F.2
  • 57
    • 0031079732 scopus 로고    scopus 로고
    • Isolation of villous microvessels from the human placenta
    • Kacemi A, Challier JC, Galtier M, Olive G. Isolation of villous microvessels from the human placenta. C R Acad Sci III. 1997;320(2):171-7.
    • (1997) C R Acad Sci III , vol.320 , Issue.2 , pp. 171-177
    • Kacemi, A.1    Challier, J.C.2    Galtier, M.3    Olive, G.4
  • 59
    • 79955008189 scopus 로고    scopus 로고
    • Angiogenic signaling aberrantly induced by tumor hypoxia
    • Takenaga K. Angiogenic signaling aberrantly induced by tumor hypoxia. Front Biosci (Landmark Ed). 2011;16:31-48.
    • (2011) Front Biosci (Landmark Ed) , vol.16 , pp. 31-48
    • Takenaga, K.1
  • 60
    • 84873774168 scopus 로고
    • Growth and metastasis of tumor in organ culture
    • Folkman J, Long Jr DM, Becker FF. Growth and metastasis of tumor in organ culture. Cancer. 1963;16:453-67.
    • (1963) Cancer , vol.16 , pp. 453-467
    • Folkman, J.1    Long, D.M.2    Becker, F.F.3
  • 61
    • 33745141942 scopus 로고    scopus 로고
    • Angiogenesis and cancer: a cross-talk between basic science and clinical trials (the "do ut des" paradigm)
    • de Castro JG, Puglisi F, de Azambuja E, El Saghir NS, Awada A. Angiogenesis and cancer: a cross-talk between basic science and clinical trials (the "do ut des" paradigm). Crit Rev Oncol Hematol. 2006;59(1):40-50.
    • (2006) Crit Rev Oncol Hematol , vol.59 , Issue.1 , pp. 40-50
    • Castro, J.G.1    Puglisi, F.2    Azambuja, E.3    Saghir, N.S.4    Awada, A.5
  • 62
    • 84866155045 scopus 로고    scopus 로고
    • Antiangiogenic and anticancer molecules in cartilage
    • Patra D, Sandell LJ. Antiangiogenic and anticancer molecules in cartilage. Expert Rev Mol Med. 2012;19;14:e10.
    • (2012) Expert Rev Mol Med , vol.19 , Issue.14 , pp. e10
    • Patra, D.1    Sandell, L.J.2
  • 63
    • 15344340324 scopus 로고    scopus 로고
    • Bevacizumab: antiangiogenic cancer therapy
    • Culy C. Bevacizumab: antiangiogenic cancer therapy. Drugs Today (Barc). 2005;41(1):23-36.
    • (2005) Drugs Today (Barc) , vol.41 , Issue.1 , pp. 23-36
    • Culy, C.1
  • 64
    • 77649168107 scopus 로고    scopus 로고
    • Anti-vascular endothelial growth factor therapies and cardiovascular toxicity: what are the important clinical markers to target?
    • Vaklavas C, Lenihan D, Kurzrock R, Tsimberidou AM. Anti-vascular endothelial growth factor therapies and cardiovascular toxicity: what are the important clinical markers to target? Oncologist. 2010;15(2):130-41.
    • (2010) Oncologist , vol.15 , Issue.2 , pp. 130-141
    • Vaklavas, C.1    Lenihan, D.2    Kurzrock, R.3    Tsimberidou, A.M.4
  • 65
    • 80054864382 scopus 로고    scopus 로고
    • Reappraising antiangiogenic therapy for breast cancer
    • Kerbel RS. Reappraising antiangiogenic therapy for breast cancer. Breast. 2011;20 Suppl 3:S56-60.
    • (2011) Breast , vol.20 , pp. S56-60
    • Kerbel, R.S.1
  • 66
    • 33645239158 scopus 로고    scopus 로고
    • Immunoplacental therapy, a potential multi-epitope cancer vaccine
    • Harandi A. Immunoplacental therapy, a potential multi-epitope cancer vaccine. Med Hypotheses. 2006;66(6):1182-7.
    • (2006) Med Hypotheses , vol.66 , Issue.6 , pp. 1182-1187
    • Harandi, A.1
  • 67
    • 84878263190 scopus 로고    scopus 로고
    • Robo4 is an effective tumor endothelial marker for antibody-drug conjugates based on the rapid isolation of the anti-Robo4 cell-internalizing antibody
    • Yoshikawa M, Mukai Y, Okada Y, Tsumori Y, Tsunoda S, Tsutsumi Y, et al. Robo4 is an effective tumor endothelial marker for antibody-drug conjugates based on the rapid isolation of the anti-Robo4 cell-internalizing antibody. Blood. 2013;121(14):2804-13.
    • (2013) Blood , vol.121 , Issue.14 , pp. 2804-2813
    • Yoshikawa, M.1    Mukai, Y.2    Okada, Y.3    Tsumori, Y.4    Tsunoda, S.5    Tsutsumi, Y.6
  • 68
    • 84855915831 scopus 로고    scopus 로고
    • Identification and angiogenic role of the novel tumor endothelial marker CLEC14A
    • Mura M, Swain RK, Zhuang X, Vorschmitt H, Reynolds G, Durant S, et al. Identification and angiogenic role of the novel tumor endothelial marker CLEC14A. Oncogene. 2012;31(3):293-305.
    • (2012) Oncogene , vol.31 , Issue.3 , pp. 293-305
    • Mura, M.1    Swain, R.K.2    Zhuang, X.3    Vorschmitt, H.4    Reynolds, G.5    Durant, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.